NEJM Group expands to engage with medical community in China via new digital platform

NEJM 医学前沿 opens doors to help advance Chinese clinical practice and medical research through shared content and commentary

(21 November 2016, Boston, MA)  NEJM Group, publisher of the New England Journal of Medicine (NEJM), today took important steps to strengthen ties with the Chinese medical community through the introduction of NEJM 医学前沿 (Yi Xue Qian Yan), which translates to NEJM Frontiers in Medicine.

NEJM Yi Xue Qian Yan delivers select, translated articles from the New England Journal of Medicine and NEJM Journal Watch to health care professionals in China. The Chinese-language digital platform addresses a growing need for trusted medical information regarding non-communicable diseases in China, including cardiovascular disease, stroke, diabetes and cancer.

NEJM Yi Xue Qian Yan, developed in collaboration with Jiahui Medical Research and Education Group (JMRE), is the authorized digital resource for providing Chinese readers with weekly content. The utmost care is given to ensuring the quality and accuracy of the translations. NEJM Yi Xue Qian Yan features commentary from Chinese medical experts, providing context and enhanced understanding of the impact of important medical advances on patient care in China. NEJM Yi Xue Qian Yan is available for free to registered users via a mobile app and online at http://www.nejmqianyan.cn/.

“China is facing serious public health issues on a large scale,” said Jeffrey Drazen, M.D., Editor-in-Chief of the New England Journal of Medicine. “By launching NEJM Yi Xue Qian Yan with JMRE, we are able to deliver the best medical information in the most useful format to researchers and clinicians in China, with the shared goal of improving practice and patient care.” An NEJM editorial about NEJM 医学前沿, “Making An Impact on Clinical Practice and Research in China,” was published on November 21.

The JMRE publishing team includes editorial and business staff as well as networks of translators and physician-scientist contributors.

NEJM Yi Xue Qian Yan is published by Shanghai Scientific & Technical Publishers, which was founded in January 1956 and is one of the oldest and largest comprehensive scientific and technical publishing houses in China.

About NEJM Group (http://nejmgroup.org/):
NEJM Group creates high-quality medical resources for research, learning, practice, and professional development. Designed to meet the demand for essential medical knowledge and innovation among academic researchers and teachers, physicians, clinicians, executives, and others in health care, NEJM Group products include the New England Journal of Medicine, NEJM Journal Watch, NEJM Knowledge+, and NEJM Catalyst. NEJM Group is a division of the Massachusetts Medical Society.

About JMRE (http://www.nejmqianyan.cn/):
Jiahui Medical Research & Education Group (JMRE) is a subsidiary of Carebridge, a Shanghai-based integrated healthcare ecosystem that is developing China’s largest private tertiary hospital, a network of primary care and specialist ambulatory clinics, and a precision medicine firm, amongst other initiatives. JMRE’s mission is to raise awareness of medical advances among clinicians through translated content, thoughtful commentary, and education programs, enhancing the quality of Chinese-originated medical research and establishing stronger links between Chinese scientists and the international medical community.

This press release is here.

More here.

两周前,美国 NEJM集团与中国上海的嘉会医学研究与教育集团JMRE 携手启动了一项战略合作项目——《NEJM医学前沿》。这一线上医学资源由《NEJM医学前沿》官网(www.nejmqianyan.cn)和移动客户端组成。该项目汇集了发表于《新英格兰医学杂志》(NEJM)和《新英格兰医学杂志期刊荟萃》(NEJM Journal Watch)的 一批重量级论文的中文翻译,今后每周将与《新英格兰医学杂志》几乎同步发布重要文章的译文;同时,部分译文附有由中国专家原创的相关述评。

近几十年来,中国在医学研究和患者医疗方面取得了长足的进步。但随着经济发展,中国人口的快速老龄化及生活方式的改变,导致了心血管疾病、脑卒中、糖尿病和癌症等慢病负担日益增长。作为权威性科学期刊,NEJM 囊括了对中国医疗从业者有广泛价值的资料。而这些内容只有便于读者获取,才能发挥最大的作用,广泛服务于大众;因此,采用其母语(中文)才能实现准确快速的传播。《NEJM医学前沿》将翻译来自于《新英格兰医学杂志》和《新英格兰医学杂志期刊荟萃》的高质量医学和科学内容,并把高品质译文带给中国的医务工作者、科研人员和教育工作者。我们致力于改进中国的临床实践,使中国融入国际医学的主流。

《NEJM医学前沿》创刊号中收录了近五年来发表的众多精品论文的译文,其中150余篇选自NEJM,100余篇选自《NEJM期刊荟萃》。论文题材偏重于癌症、心脑血管疾病和糖尿病,其中近20篇文章附有由中国医生科学家撰写的述评。

《NEJM医学前沿》计划每周翻译和出版发表于《新英格兰医学杂志》和《新英格兰医学杂志期刊荟萃》的新内容。我们的选题着重于上述三大疾病领域,今后会逐渐扩展到更为广泛的医学范畴。《NEJM医学前沿》还全文翻译NEJM每周的目录,并提供目录的NEJM官网链接。读者完成方便而安全的注册后,即可免费获取《NEJM医学前沿》的内容,还可以通过NEJM官网获取《NEJM医学前沿》上的所有译文链接。

我们的宗旨是通过提供可靠的医学信息来促进全人类健康,相信您在《NEJM医学前沿》会得到您所需求的重要信息。